CRISPR-targeted genome editing of human induced pluripotent stem cell-derived hepatocytes for the treatment of Wilson's disease.
JHEP Rep
; 4(1): 100389, 2022 Jan.
Article
in En
| MEDLINE
| ID: mdl-34877514
AFP, alpha-fetoprotein; ALB, albumin; ATP7B, ATPase copper transporting beta; ATPase copper transporting beta polypeptide (ATP7B); Clustered regularly interspaced palindromic repeats (CRISPR)/Cas9; EB, embryoid body; RFLP, restriction fragment length polymorphism; Single-stranded Oligodeoxynucleotide (ssODN); TGN, trans-Golgi network; WD, Wilson's disease; Wilson's disease; cell therapy; gene correction; iHep(s), iPSC-derived hepatocyte(s); iPSC, induced pluripotent stem cell; iPSC-derived hepatocytes (iHeps); induced pluripotent stem cell (iPSC); sgRNA, single guide RNA; ssODN, single-stranded oligodeoxynucleotide
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Prognostic_studies
Language:
En
Journal:
JHEP Rep
Year:
2022
Document type:
Article
Affiliation country:
China